Ascent Group’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
VCM
VPM
Ascent Group's AMGN Position: Q1 2026 in Review
Ascent Group reduced its Amgen (AMGN) stake by 16% in Q1 2026, selling an estimated $530K and leaving 7,925 shares worth $2.79M. The position accounts for 0.1% of the portfolio, ranked #196.
Ascent Group first reported a position in AMGN in Q4 2021 and has held it in 18 quarters since. The position peaked at $6.95M in Q2 2022. 3,130 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Ascent Group held 7,925 shares of Amgen worth $2.79M as of Q1 2026.
- Ascent Group sold 1,487 Amgen shares in Q1 2026, an estimated $530K.
- Amgen made up 0.1% of Ascent Group's portfolio in Q1 2026, its #196 holding.
- Ascent Group first reported a position in Amgen in Q4 2021 and has held it in 18 quarters since.
- Ascent Group's Amgen position peaked at $6.95M in Q2 2022.
- 3,130 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Ascent Group's 13F filing for Q1 2026, filed 15 May 2026.